157 related articles for article (PubMed ID: 32660395)
41. Dangerous Duplicity: The Dual Functions of Casein Kinase 1 in Parasite Biology and Host Subversion.
Rachidi N; Knippschild U; Späth GF
Front Cell Infect Microbiol; 2021; 11():655700. PubMed ID: 33869086
[TBL] [Abstract][Full Text] [Related]
42. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
[TBL] [Abstract][Full Text] [Related]
43. Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism.
Bryja V; Schulte G; Rawal N; Grahn A; Arenas E
J Cell Sci; 2007 Feb; 120(Pt 4):586-95. PubMed ID: 17244647
[TBL] [Abstract][Full Text] [Related]
44. The conserved C-terminal residues of FAM83H are required for the recruitment of casein kinase 1 to the keratin cytoskeleton.
Kuga T; Inoue N; Sometani K; Murataka S; Saraya M; Sugita R; Mikami T; Takeda Y; Taniguchi M; Nishida K; Yamagishi N
Sci Rep; 2022 Jul; 12(1):11819. PubMed ID: 35821396
[TBL] [Abstract][Full Text] [Related]
45. Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis.
Schittek B; Sinnberg T
Mol Cancer; 2014 Oct; 13():231. PubMed ID: 25306547
[TBL] [Abstract][Full Text] [Related]
46. Purification of CK1 by affinity chromatography on immobilised axin.
Reinhardt J; Ferandin Y; Meijer L
Protein Expr Purif; 2007 Jul; 54(1):101-9. PubMed ID: 17434749
[TBL] [Abstract][Full Text] [Related]
47. Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors.
Wager TT; Galatsis P; Chandrasekaran RY; Butler TW; Li J; Zhang L; Mente S; Subramanyam C; Liu S; Doran AC; Chang C; Fisher K; Grimwood S; Hedde JR; Marconi M; Schildknegt K
ACS Chem Neurosci; 2017 Sep; 8(9):1995-2004. PubMed ID: 28609096
[TBL] [Abstract][Full Text] [Related]
48. Microtubules depolymerization caused by the CK1 inhibitor IC261 may be not mediated by CK1 blockage.
Stöter M; Krüger M; Banting G; Henne-Bruns D; Knippschild U
PLoS One; 2014; 9(6):e100090. PubMed ID: 24937750
[TBL] [Abstract][Full Text] [Related]
49. Casein kinase 1: Complexity in the family.
Cheong JK; Virshup DM
Int J Biochem Cell Biol; 2011 Apr; 43(4):465-9. PubMed ID: 21145983
[TBL] [Abstract][Full Text] [Related]
50. Kinase activity of casein kinase 1 delta (CK1δ) is modulated by protein kinase C α (PKCα) by site-specific phosphorylation within the kinase domain of CK1δ.
Meng Z; Böhm T; Xu P; Henne-Bruns D; Peifer C; Witt L; Knippschild U; Bischof J
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):710-721. PubMed ID: 31096047
[TBL] [Abstract][Full Text] [Related]
51. Structure-function study of a novel inhibitor of the casein kinase 1 family in
Saito AN; Matsuo H; Kuwata K; Ono A; Kinoshita T; Yamaguchi J; Nakamichi N
Plant Direct; 2019 Sep; 3(9):e00172. PubMed ID: 31549020
[TBL] [Abstract][Full Text] [Related]
52. CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.
Ianes C; Xu P; Werz N; Meng Z; Henne-Bruns D; Bischof J; Knippschild U
Amino Acids; 2016 Feb; 48(2):579-92. PubMed ID: 26464264
[TBL] [Abstract][Full Text] [Related]
53. A comparative study of structural and conformational properties of casein kinase-1 isoforms: insights from molecular dynamics and principal component analysis.
Singh SP; Gupta DK
J Theor Biol; 2015 Apr; 371():59-68. PubMed ID: 25665722
[TBL] [Abstract][Full Text] [Related]
54. Casein Kinase 1 and Human Disease: Insights From the Circadian Phosphoswitch.
Francisco JC; Virshup DM
Front Mol Biosci; 2022; 9():911764. PubMed ID: 35720131
[TBL] [Abstract][Full Text] [Related]
55. Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. Evidence that phosphorylated residues are not strictly required for efficient targeting by casein kinase-1.
Marin O; Meggio F; Sarno S; Andretta M; Pinna LA
Eur J Biochem; 1994 Jul; 223(2):647-53. PubMed ID: 8055935
[TBL] [Abstract][Full Text] [Related]
56. Design, Synthesis and Biological Evaluation of Isoxazole-Based CK1 Inhibitors Modified with Chiral Pyrrolidine Scaffolds.
Luxenburger A; Schmidt D; Ianes C; Pichlo C; Krüger M; von Drathen T; Brunstein E; Gainsford GJ; Baumann U; Knippschild U; Peifer C
Molecules; 2019 Mar; 24(5):. PubMed ID: 30832206
[TBL] [Abstract][Full Text] [Related]
57. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.
Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S
J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487
[TBL] [Abstract][Full Text] [Related]
58. Targeting casein kinase 1 for cancer therapy: current strategies and future perspectives.
Long NH; Lee SJ
Front Oncol; 2023; 13():1244775. PubMed ID: 38023245
[TBL] [Abstract][Full Text] [Related]
59. Dynamic conformational ensembles regulate casein kinase-1 isoforms: Insights from molecular dynamics and molecular docking studies.
Singh SP; Gupta DK
Comput Biol Chem; 2016 Apr; 61():39-46. PubMed ID: 26788877
[TBL] [Abstract][Full Text] [Related]
60. Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors.
Liu F; Ma XH; Ule J; Bibb JA; Nishi A; DeMaggio AJ; Yan Z; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11062-8. PubMed ID: 11572969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
